India has a core competence of producing cost-effective pharma products and should set a target of producing 20 per cent of world generics products, said former President Abdul Kalam.
Speaking after the inauguration of 64th Indian Pharmaceutical Congress at SRM University, here on Thursday, Kalam said the global production of pharmaceuticals, branded and generics put together is more than $550 billion and the Indian pharma industry, which has a turnover of $30 billion, should aim to be a leader in drug production.
Stating that by 2020, the demand for pharmacists will be around 1.7 million in our country, he called for the need for partnership between pharma industries and pharma institutions in drug development and clinical research.He said Indian pharma industrialists have to aggressively shift paradigms and look beyond process development capabilities towards new drug research with adequate attention to quality, costs, and time dimensions.